PGK1 antibody (AA 117-145)
Quick Overview for PGK1 antibody (AA 117-145) (ABIN3032224)
Target
See all PGK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 117-145
-
Cross-Reactivity (Details)
- Expected species reactivity: Primate, Rat
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 117-145 from the human protein was used as the immunogen for this PGK1 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the PGK1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,IHC (Paraffin): 1:10-1:100,Immunofluorescence: 1:10-1:50,Flow Cytometry: 1:10-1:50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the PGK1 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- PGK1 (Phosphoglycerate Kinase 1 (PGK1))
-
Alternative Name
- PGK1
-
Background
- Also known as ATP:3-phosphoglycerate 1-phosphotransferase (EC 2.7.2.3), this major enzyme in glycolysis catalyzes the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate, generating one molecule of ATP. New blood vessel formation or angiogenesis is critical for tumor expansion and metastasis. Lay et al. (2000) showed that the plasmin reductase isolated from conditioned medium of fibrosarcoma cells is the glycolytic enzyme phosphoglycerate kinase. They concluded that phosphoglycerate kinase not only functions in glycolysis but is secreted by tumor cells and participates in the angiogenic process as a disulfide reductase.
-
UniProt
- P00558
-
Pathways
- Cellular Glucan Metabolic Process
Target
-